ReviewCurrent treatment options in oncology2020
Current Challenge: Endoscopic Submucosal Dissection of Superficial Non-ampullary Duodenal Epithelial Tumors.
Review in Current treatment options in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 24 citations in OpenAlex.
- Comparative efficacy and safety of hybrid versus conventional endoscopic submucosal dissection for non-ampullary duodenal submucosal tumors.Surgical endoscopy · 2026Article
- Endoscopic Resection for Non‑ampullary Duodenal Lesions: 13 Years of Experience from a Large Tertiary Center in China.Digestive diseases and sciences · 2026Observational
- Novel Traction-Assisted Endoscopic Resection for Superficial Non-ampullary Duodenal Epithelial Tumors: 15-Year Experience from a Large Tertiary Center.Digestive diseases and sciences · 2026Article
- Gaining Traction: How Adjustable Clip-and-Rubber Band Traction Improves Duodenal Endoscopic Submucosal Dissection.Digestive diseases and sciences · 2026Article
- The impact of multidisciplinary team on surgical procedure and complications in duodenal tumor patients.BMC cancer · 2026Article
- Submucosal tunneling endoscopic resection combined with sequential traction for a large duodenal bulb adenoma.Gastroenterology report · 2026Article
- Outcomes and Limitations of Duodenal Endoscopic Submucosal Dissection in the United States.Digestive diseases and sciences · 2025Article
- Nonexposure full-thickness resection in a laparoscopic-endoscopic approach as a hybrid technique for nonampullary duodenal neuroendocrine tumor.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2025Article
- A method of "Noninjecting Resection using Bipolar Soft coagulation mode; NIRBS" for superficial non-ampullary duodenal epithelial tumor: a pilot study.BMC gastroenterology · 2024Article
- Safety of cold resection of non-ampullary duodenal polyps: Systematic review and meta-analysis.Endoscopy international open · 2024Article
- Same duodenal neuroendocrine tumors, different endoscopic resection methods: a case report and literature review.Frontiers in medicine · 2024Article
- Safety of Duodenal Endoscopic Submucosal Dissection for Superficial Non-Ampullary Duodenal Epithelial Tumor: A Single-Center Study in the United States.Journal of clinical medicine · 2023Article
- Settings of a novel electrosurgical generator to enable efficient and safe submucosal endoscopic procedures.Endoscopy international open · 2023Article
- Current endoscopic diagnosis treatment strategy for superficial nonampullary duodenal tumours.European journal of medical research · 2022Review
- Recent approach for preventing complications in upper gastrointestinal endoscopic submucosal dissection.DEN open · 2022Review
- Robotic-assisted vs non-robotic traction techniques in endoscopic submucosal dissection for malignant gastrointestinal lesions.Frontiers in oncology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
opinion statementWith the widespread use of esophagogastroduodenoscopy in recent years, the detection rate of superficial non-ampullary duodenal epithelial tumors (SNADETs) is increasing. Most SNADETs are early-stage adenocarcinoma or benign conditions, including adenoma. Therefore, endoscopic resection is desirable from the perspective of quality of life. However, endoscopic resection for SNADETs has not yet been established. Endoscopic submucosal dissection (ESD) is the most promising method for the treatment of SNADETs, because ESD provides a high rate of en bloc resection and a low rate of recurrence regardless of the tumor size. However, the difficulty of the procedure and a high rate of severe adverse events including perforation and bleeding have become major problems. Various preventive countermeasures for adverse events, such as use of specific devices, endoscope stabilization methods, and endoscopic closure of the post-ESD ulcer using clips, are reported to reduce the risk of the adverse events of ESD for SNADETs. This article reviews and highlights the current state of ESD for SNADETs and new challenges towards safe and effective ESD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.